Primary immunodeficiency (PI), a batch of diseases that compromise the immune system, is the subject of a social media campaign launched by drugmaker Shire plc.
In an April 24 press release, Shire said the #PIPostsThanks campaign will draw attention to care providers treating PI. The April 22-29 campaign will coincide with World PI Week, a strategy to draw attention to the often-treatable illness.
In the announcement, Kasha Witkos, Shire’s global head of immunology, said the hashtag campaign will reinforce the firm’s efforts to battle the syndrome.
“We hope to raise awareness of this devastating disorder and offer our own thanks and ongoing commitment to innovating on behalf of PI patients around the world,” Witkos said in the release. “We are determined to make a meaningful difference for patients with PI.”
The thank-you campaign will be available via three social media channels – MyIgSource Facebook (intended for U.S.audiences), Rare2Aware Facebook (intended for audiences outside of the U.S.) and Rare2Aware Instagram (intended for audiences outside of the U.S.).
Scientists estimate 6 million patients may suffer from the disease, which takes a decade or longer to properly diagnose, the release said.
